Radar

EQS-News: EnviTec Biogas AG is Germany’s largest biogas producer and continues to invest in expansion

Retrieved on: 
Wednesday, April 10, 2024
EUR, Annual report, EBT, CFO, GHG, History, Acquisition, Plant, Investment, CO2, Kilowatt-hour, Hydrogen, Radar, Food industry, Management

21 March 2024 – The biggest investment programme in the history of EnviTec Biogas AG is currently underway, with a budget of EUR 100 million.

Key Points: 
  • 21 March 2024 – The biggest investment programme in the history of EnviTec Biogas AG is currently underway, with a budget of EUR 100 million.
  • Operation of the plants is 100% in-house by EnviTec itself or with partners from the agriculture sector.
  • In other European countries we operate another seven plants with a nominal annual output of 180 GWh,” Fischer continues.
  • With the completion of the new investments begun in 2023, annual biogas generation capacity will rise to around 1,800 GWh/year in 2025.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ventyx, and Anavex and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, April 9, 2024
Psoriasis, Form, Patient, Defendant, News, IPO, Crohn's disease, Security (finance), Inflammation, Rett syndrome, Prospectus, Complaint, P.C, Clinical trial, MCI, Radar, File, Register, Pharmaceutical industry

The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.

Key Points: 
  • The Company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease.
  • In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • On November 6, 2023, during after-market hours, Ventyx issued a press release announcing results from the Phase 2 SERENITY Trial.
  • For more information on the Anavex class action go to: https://bespc.com/cases/AVXL

Netcoins Canada announces the addition of 4 new Coins for Trading

Retrieved on: 
Monday, April 8, 2024
TIA, Meme, RWA, AI, Eye, Strategy, Cloud computing, Radar, Machine learning, EVM, Blockchain, Cryptocurrency

“Netcoins Canada is excited to add the following new crypto assets to its platform on April 9th.

Key Points: 
  • “Netcoins Canada is excited to add the following new crypto assets to its platform on April 9th.
  • These coins will be available for users to Buy, Sell, Deposit and Withdraw, allowing full control for users over the trading lifecycle.
  • Netcoins now offers more than 45 crypto assets and is firmly entrenched as a market leader in Canada.
  • Netcoins remains committed to being the one-stop shop for Canadians to safely access the lucrative and diverse crypto market.

Pittsburgh Post-Gazette Features One of Zefiro Methane’s Subsidiaries in an Article on Orphaned Wells in Pennsylvania

Retrieved on: 
Friday, April 5, 2024
Carbon, Press, Philosophy, Federation, METHANE, News, Hope, United, Radar, P&G, Water, Environmental Defense Fund, Pharmaceutical industry

FORT LAUDERDALE, Fla., April 05, 2024 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (the “Company”, “Zefiro”, or “ZEFI”) is pleased to announce that earlier this week, the Pittsburgh Post-Gazette newspaper published an article on opportunities stemming from the orphaned well problem in the state of Pennsylvania, featuring commentary and insights from Plants & Goodwin, Inc. (“Plants & Goodwin” or “P&G”), one of Zefiro’s operating subsidiaries which was acquired by the Company in May 2023. Plants & Goodwin is headquartered in Bradford, Pennsylvania, and also operates in the states of New York, Ohio, and West Virginia.

Key Points: 
  • An untold amount of orphaned oil and gas wells exist in the state of Pennsylvania.
  • Plants & Goodwin is headquartered in Bradford, Pennsylvania, and also operates in the states of New York, Ohio, and West Virginia.
  • Please access the Investors section of the Company’s website for a version of this press release containing all published media.
  • In contrast to legacy ‘ESG’ values, we do not seek to divert capital away from the oil and gas industry.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Ventyx, and Anavex and Encourages Investors to Contact the Firm

Retrieved on: 
Friday, April 5, 2024
Bitcoin, Research, Bankruptcy, Psoriasis, Register, Form, Patient, Defendant, News, IPO, Crohn's disease, Security (finance), Data mining, Inflammation, Rett syndrome, Prospectus, Complaint, Hut 8, P.C, Clinical trial, MCI, Radar, File, Mergers and acquisitions, Cryptocurrency

In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).

Key Points: 
  • In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).
  • USBTC held a 50% interest in a joint venture bitcoin mining facility, located in King Mountain, Texas (the “King Mountain JV”), which was acquired in the Merger.
  • In addition, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects.
  • For more information on the Anavex class action go to: https://bespc.com/cases/AVXL

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders

Retrieved on: 
Thursday, April 4, 2024
Telephone, Patient, News, LLP, CLASS, Rett syndrome, Clinical trial, MCI, Radar, NEXT, COST, Court, Cryptocurrency

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Anavex Life Sciences investors who were adversely affected by alleged securities fraud between February 1, 2022 and January 1, 2024.
  • Follow the link below to get more information and be contacted by a member of our team:
    AVXL investors may also contact Joseph E. Levi, Esq.
  • For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services’ Top 50 Report as one of the top securities litigation firms in the United States.

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for Investors – Contact The Gross Law Firm

Retrieved on: 
Wednesday, April 3, 2024
Patient, News, Rett syndrome, Clinical trial, MCI, Radar, Fraud, NEXT, Security (finance)

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Anavex Life Sciences Corporation (NASDAQ: AVXL).

Key Points: 
  • NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Anavex Life Sciences Corporation (NASDAQ: AVXL).
  • Shareholders who purchased shares of AVXL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
  • The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices.
  • The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

Music Licensing, Inc. Addresses Shareholder Inquiries Regarding Stock Consolidation and Strategic Acquisitions

Retrieved on: 
Tuesday, April 2, 2024
Skrillex, Common, FINRA, OTC, Music licensing, Deadmau5, Radar

As of April 2, 2024, there are 3,001,750,199 shares of Common Stock outstanding, along with one share of Preferred J stock outstanding.

Key Points: 
  • As of April 2, 2024, there are 3,001,750,199 shares of Common Stock outstanding, along with one share of Preferred J stock outstanding.
  • Following the anticipated stock consolidation to be processed by FINRA, the outstanding shares are expected to be reduced to approximately 6,004.
  • While the company had to exercise caution to ensure sufficient cash reserves until the completion of the stock consolidation by FINRA, it remains confident in its ability to pursue strategic acquisitions thereafter.
  • "The forthcoming stock consolidation positions us well to capitalize on strategic acquisitions, further enhancing our position as a diversified holding company."

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Anavex, and Innoviz and Encourages Investors to Contact the Firm

Retrieved on: 
Sunday, March 31, 2024
Bitcoin, Research, Bankruptcy, Patient, Defendant, News, Data mining, Rett syndrome, Complaint, Hut 8, P.C, Clinical trial, MCI, Radar, Mergers and acquisitions, Cryptocurrency

Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.

Key Points: 
  • Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
  • Additional information about each case can be found at the link provided.
  • In November 2023, Hut 8 formed following the merger of Hut 8 Mining Corp. (“Legacy Hut”) and U.S. Data Mining Group, Inc. d/b/a US Bitcoin Corp. (“USBTC”) (the “Merger”).
  • For more information on the Innoviz class action go to: https://bespc.com/cases/INVZ

Investors in Anavex Life Sciences Corporation Should Contact Levi & Korsinsky Before May 13, 2024 to Discuss Your Rights – AVXL

Retrieved on: 
Thursday, March 28, 2024
Telephone, Patient, News, LLP, CLASS, Rett syndrome, Clinical trial, MCI, Radar, NEXT, COST, Court

NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.

Key Points: 
  • NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Anavex Life Sciences Corporation ("Anavex Life Sciences" or the "Company") (NASDAQ: AVXL) of a class action securities lawsuit.
  • CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Anavex Life Sciences investors who were adversely affected by alleged securities fraud between February 1, 2022 and January 1, 2024.
  • Follow the link below to get more information and be contacted by a member of our team:
    AVXL investors may also contact Joseph E. Levi, Esq.
  • If you suffered a loss in Anavex Life Sciences during the relevant time frame, you have until May 13, 2024 to request that the Court appoint you as lead plaintiff.